Home
Ottar Kjell Nygård's picture

Ottar Kjell Nygård

Professor
  • E-mailOttar.Nygard@uib.no
  • Phone+47 55 97 30 64
  • Visitor Address
    Haukeland universitetssykehus, Laboratoriebygget
  • Postal Address
    Postboks 7804
    5020 Bergen
Academic article
  • Show author(s) 2019. Using metabolic profiling and gene expression analyses to explore molecular effects of replacing saturated fat with polyunsaturated fat-a randomized controlled dietary intervention study. American Journal of Clinical Nutrition. 1239-1250.
  • Show author(s) 2019. Tryptophan catabolites as metabolic markers of vitamin B-6 status evaluated in cohorts of healthy adults and cardiovascular patients . American Journal of Clinical Nutrition. 178-186.
  • Show author(s) 2019. Short-term activation of peroxisome proliferator-activated receptors α and γ induces tissue-specific effects on lipid metabolism and fatty acid composition in male Wistar rats. PPAR Research. 1-12.
  • Show author(s) 2019. Plasma amino acids and incident type 2 diabetes in patients with coronary artery disease. Diabetes Care. 1225-1233.
  • Show author(s) 2019. Elevated plasma cystathionine is associated with increased risk of mortality among patients with suspected or established coronary heart disease. American Journal of Clinical Nutrition. 1546-1554.
  • Show author(s) 2019. Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients. European Heart Journal. 371-380.
  • Show author(s) 2019. Creatinine, total cysteine and uric acid are associated with serum retinol in patients with cardiovascular disease. European Journal of Nutrition.
  • Show author(s) 2019. Aiming toWards Evidence baSed inTerpretation of Cardiac biOmarkers in patients pResenting with chest pain-the WESTCOR study: study design. Scandinavian Cardiovascular Journal. 280-285.
  • Show author(s) 2018. Plasma concentrations and dietary intakes of choline and betaine in association with atrial fibrillation risk: Results from 3 prospective cohorts with different health profiles. Journal of the American Heart Association (JAHA). 11 pages.
  • Show author(s) 2015. Vitamin D status was not associated with 'one-year' progression of coronary artery disease, assessed by coronary angiography in statin-treated patients. European Journal of Preventive Cardiology (EJPC). 594-602.
  • Show author(s) 2015. Use of loop diuretics is associated with increased mortality in patients with suspected coronary artery disease, but without systolic heart failure or renal impairment: an observational study using propensity score matching. PLOS ONE. 13 pages.
  • Show author(s) 2015. Trends in 28-day and 1-year mortality rates in patients hospitalized for a first acute myocardial infarction in Norway during 2001-2009: A Cardiovascular disease in Norway (CVDNOR) project. Journal of Internal Medicine. 353-361.
  • Show author(s) 2015. Refined phenotyping identifies links between preeclampsia and related diseases in a Norwegian preeclampsia family cohort. Journal of Hypertension. 2294-2302.
  • Show author(s) 2015. Plasma dimethylglycine, nicotine exposure and risk of low bone mineral density and hip fracture: the Hordaland Health Study. Osteoporosis International. 1573-1583.
  • Show author(s) 2015. Plasma choline, smoking, and long-term prognosis in patients with stable angina pectoris. European Journal of Preventive Cardiology (EJPC). 606-614.
  • Show author(s) 2015. Novel inflammatory biomarkers in primary hyperparathyroidism. European Journal of Endocrinology. 9-17.
  • Show author(s) 2015. Non-fasting triglycerides predict incident acute myocardial infarction among those with favourable HDL-cholesterol: Cohort Norway. European Journal of Preventive Cardiology (EJPC). 872-881.
  • Show author(s) 2015. Markers of vitamin B6 status and metabolism as predictors of incident cancer: The Hordaland Health Study. International Journal of Cancer. 2932-2939.
  • Show author(s) 2015. Kynurenines as predictors of acute coronary events in the Hordaland Health Study. International Journal of Cardiology. 18-24.
  • Show author(s) 2015. Hypertriglyceridemic-Waist Phenotype is a Useful Global Assessment Tool for Predicting Acute Myocardial Infarction. Journal of Cardiovascular Diseases & Diagnosis. 1-6.
  • Show author(s) 2015. Glycated hemoglobin and long-term prognosis in patients with suspected stable angina pectoris without diabetes mellitus: A prospective cohort study. Atherosclerosis. 115-120.
  • Show author(s) 2015. Elevated plasma dimethylglycine is a risk marker of mortality in patients with coronary heart disease. European Journal of Preventive Cardiology (EJPC). 743-752.
  • Show author(s) 2015. Effect of the Lookback period's length used to identify incident acute myocardial infarction on the observed trends on incidence rates and survival: cardiovascular disease in Norway project. Circulation. Cardiovascular Quality and Outcomes. 376-382.
  • Show author(s) 2015. Clinical significance of late enhancement and regional wall remodeling assessed by 3T magnetic resonance imaging. Clinical Medicine Insights: Cardiology. 17-24.
  • Show author(s) 2015. Circulating B-vitamins and smoking habits are associated with serum polyunsaturated fatty acids in patients with suspected coronary heart disease: A cross-sectional study. PLOS ONE. 14 pages.
  • Show author(s) 2015. Associations of plasma kynurenines with risk of acute myocardial infarction in patients with stable angina pectoris. Arteriosclerosis, Thrombosis and Vascular Biology. 455-462.
  • Show author(s) 2015. A protein extract from chicken reduces plasma homocysteine in rats. Nutrients. 4498-4511.
  • Show author(s) 2015. A Phospholipid-Protein Complex from Antarctic Krill Reduced Plasma Homocysteine Levels and Increased Plasma Trimethylamine-N-Oxide (TMAO) and Carnitine Levels in Male Wistar Rats. Mar. Drugs. Marine Drugs. 5706-5721.
  • Show author(s) 2014. Vitamins B2 and B6 as determinants of kynurenines and related markers of interferon-gamma-mediated immune activation in the community-based Hordaland health study. British Journal of Nutrition. 1065-1072.
  • Show author(s) 2014. Trends in acute myocardial infarction event rates and risk of recurrences after an incident event in Norway 1994 to 2009 (from a cardiovascular disease in Norway project). American Journal of Cardiology. 1777-1781.
  • Show author(s) 2014. Smoking and body fat mass in relation to bone mineral density and hip fracture: The Hordaland Health Study. PLOS ONE. 9 pages.
  • Show author(s) 2014. Sarcosine and other metabolites along the choline oxidation pathway in relation to prostate cancer – a large nested case-control study within the JANUS cohort in Norway. International Journal of Cancer. 197-206.
  • Show author(s) 2014. Plasma methionine, choline, betaine, and dimethylglycine in relation to colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Annals of Oncology. 1609-1615.
  • Show author(s) 2014. Plasma choline, nicotine exposure, and risk of low bone mineral density and hip fracture: the Hordaland Health Study. Journal of Bone and Mineral Research. 242-250.
  • Show author(s) 2014. Most blood biomarkers related to vitamin status, one-carbon metabolism, and the kynurenine pathway show adequate preanalytical stability and within-person reproducibility to allow assessment of exposure or nutritional status in healthy women and cardiovascular patients. Journal of Nutrition. 784-790.
  • Show author(s) 2014. Interferon-γ-induced inflammatory markers and the risk of cancer: The Hordaland Health Study. Cancer. 3370-3377.
  • Show author(s) 2014. Interactions between plasma concentrations of folate and markers of vitamin B12 status with cognitive performance in elderly people not exposed to folic acid fortification: the Hordaland Health Study. British Journal of Nutrition. 1085-1095.
  • Show author(s) 2014. Implications of changing definitions of myocardial infarction on number of events and all-cause mortality: the WHO 1979, ESC/ACC 2000, AHA 2003, and Universal 2007 definitions revisited. European Journal of Preventive Cardiology (EJPC). 1349-1357.
  • Show author(s) 2014. Hypolipidemic effect of dietary water-soluble protein extract from chicken: impact on genes regulating hepatic lipid and bile acid metabolism. European Journal of Nutrition. 193-204.
  • Show author(s) 2014. Hypolipidemic effect of dietary water-soluble protein extract from chicken: impact on genes regulating hepatic lipid and bile acid metabolism. European Journal of Nutrition. 193-204.
  • Show author(s) 2014. High consumption of farmed salmon does not disrupt the steady state of persistent organic pollutants (POP) in human plasma and adipose tissue. Journal of Toxicology and Environmental Health, Part A. 1229-1250.
  • Show author(s) 2014. Favorable trends in incidence of AMI in Norway during 2001-2009 do not include younger adults: a CVDNOR project. European Journal of Preventive Cardiology (EJPC). 1358-1364.
  • Show author(s) 2014. Evidence for increased catabolism of vitamin B-6 during systemic inflammation. American Journal of Clinical Nutrition. 250-255.
  • Show author(s) 2014. Educational inequalities in acute myocardial infarction incidence in Norway: A nationwide cohort study. PLOS ONE. 8 pages.
  • Show author(s) 2014. Educational inequalities in 28 day and 1-year mortality after hospitalisation for incident acute myocardial infarction - A nationwide cohort study. International Journal of Cardiology. 874-880.
  • Show author(s) 2014. Association of body mass index with risk of acute myocardial infarction and mortality in Norwegian male and female patients with suspected stable angina pectoris: A prospective cohort study. BMC Cardiovascular Disorders.
  • Show author(s) 2013. Urinary excretion of kynurenine and tryptophan, cardiovascular events, and mortality after elective coronary angiography. European Heart Journal. 2689-2696.
  • Show author(s) 2013. Type 2 diabetes genes : present status and data from Norwegian studies. Norsk Epidemiologi. 9-22.
  • Show author(s) 2013. The association between progression of atherosclerosis and the methylated amino acids asymmetric dimethylarginine and trimethyllysine. PLOS ONE. 9 pages.
  • Show author(s) 2013. Substrate product ratios of enzymes in the kynurenine pathway measured in plasma as indicators of functional vitamin B-6 status. American Journal of Clinical Nutrition. 934-940.
  • Show author(s) 2013. Serum folate and vitamin B12 concentrations in relation to prostate cancer risk-a Norwegian population-based nested case-control study of 3000 cases and 3000 controls within the JANUS cohort. International Journal of Epidemiology. 201-210.
  • Show author(s) 2013. Preeclampsia in healthy women and endothelial dysfunction 10 years later. American Journal of Obstetrics and Gynecology. 569.e1-569.e10.
  • Show author(s) 2013. Plasma sulfur amino acids and stearoyl-CoA desaturase activity in two caucasian populations. Prostaglandins Leukot Essent Fatty Acids 2. Prostaglandins, Leukotrienes and Essential Fatty Acids. 297-303.
  • Show author(s) 2013. Plasma stearoyl-CoA desaturase indices: Association with lifestyle, diet and body composition. Obesity. E294-E302.
  • Show author(s) 2013. Plasma dimethylglycine and risk of incident acute myocardial infarction in patients with stable angina pectoris. Arteriosclerosis, Thrombosis and Vascular Biology. 2041-2048.
  • Show author(s) 2013. Neopterin and kynurenine-tryptophan ratio as predictors of coronary events in older adults, the Hordaland Health Study. International Journal of Cardiology. 1435-1440.
  • Show author(s) 2013. Fish Oil and the Pan-PPAR Agonist Tetradecylthioacetic Acid Affect the Amino Acid and Carnitine Metabolism in Rats. PLOS ONE. 9 pages.
  • Show author(s) 2013. Evaluation of the body adiposity index in a caucasian population: the Hordaland Health Study. American Journal of Epidemiology. 586-592.
  • Show author(s) 2013. Effect of folic acid supplementation on levels of circulating monocyte chemoattractant protein-1 and the presence of intravascular ultrasound derived virtual histology thin-cap fibroatheromas in patients with stable angina pectoris. PLOS ONE. 11 pages.
  • Show author(s) 2013. Dietary intake of n-3 long-chain polyunsaturated fatty acids and risk of myocardial infarction in coronary artery disease patients with or without diabetes mellitus: a prospective cohort study. BMC Medicine.
  • Show author(s) 2013. Cardiovascular disease and diabetes mellitus in Norway during 1994 -2009: CVDNOR - nationwide research project. Norsk Epidemiologi. 101-107.
  • Show author(s) 2013. Associations between plasma polyunsaturated fatty acids, plasma stearoyl-CoA desaturase indices and body fat. Obesity. E512-E519.
  • Show author(s) 2013. Assessment of urinary betaine as a marker of diabetes mellitus in cardiovascular patients. PLOS ONE.
  • Show author(s) 2013. An immunomodulating fatty acid analogue targeting mitochondria exerts anti-atherosclerotic effect beyond plasma cholesterol-lowering activity in apoE(-/-) mice. PLOS ONE. 14 pages.
  • Show author(s) 2013. A randomised study on the effects of fish protein supplement on glucose tolerance, lipids and body composition in overweight adults. British Journal of Nutrition. 648-657.
  • Show author(s) 2013. A community-based study on determinants of circulating markers of cellular immune activation and kynurenines: the Hordaland Health Study. Clinical and Experimental Immunology. 121-130.
  • Show author(s) 2012. Vitamin B6 status and interferon-γ-mediated immune activation in primary hyperparathyroidism. Journal of Internal Medicine. 583-591.
  • Show author(s) 2012. Relative importance of risk factors for coronary heart disease - The Hordaland Homocysteine Study. Scandinavian Cardiovascular Journal. 316-323.
  • Show author(s) 2012. Omega-3 status and the relationship between plasma asymmetric dimethylarginine and risk of myocardial infarction in patients with suspected coronary artery disease. Cardiology Research and Practice. 11 pages.
  • Show author(s) 2012. Maternal tryptophan and kynurenine pathway metabolites and risk of preeclampsia. Obstetrics and Gynecology. 1243-1250.
  • Show author(s) 2012. Long-term treatment with the pan-PPAR agonist tetradecylthioacetic acid or fish oil is associated with increased cardiac content of n-3 fatty acids in rat. Lipids in Health and Disease. 11 pages.
  • Show author(s) 2012. Krill powder increases liver lipid catabolism and reduces glucose mobilization in tumor necrosis factor-alpha transgenic mice fed a high-fat diet. Metabolism: Clinical and Experimental. 1461-1472.
  • Show author(s) 2012. Free carnitine and acylcarnitines in obese patients with polycystic ovary syndrome and effects of pioglitazone treatment. Fertility and Sterility. 1620-1626,e1.
  • Show author(s) 2012. Association of plasma B-6 vitamers with systemic markers of inflammation before and after pyridoxine treatment in patients with stable angina pectoris. American Journal of Clinical Nutrition. 1072-1078.
  • Show author(s) 2011. Systemic Markers of Interferon-gamma-Mediated Immune Activation and Long-Term Prognosis in Patients With Stable Coronary Artery Disease. Arteriosclerosis, Thrombosis and Vascular Biology. 698-704.
  • Show author(s) 2011. Poor folate status predicts persistent diarrhea in 6- to 30-month-old north Indian children. Journal of Nutrition. 2226-2232.
  • Show author(s) 2011. Low plasma vitamin B-6 status affects metabolism through the kynurenine pathway in cardiovascular patients with systemic inflammation. Journal of Nutrition. 611-617.
  • Show author(s) 2011. Genetic polymorphisms in 15q25 and 19q13 Loci, cotinine levels, and risk of lung cancer in EPIC. Cancer Epidemiology, Biomarkers and Prevention. 2250-2261.
  • Show author(s) 2011. Coronary blood flow in patients with stable coronary artery disease treated long term with folic acid and vitamin B12. Coronary Artery Disease. 270-278.
  • Show author(s) 2011. Cobalamin Status Modifies the Effect of Zinc Supplementation on the Incidence of Prolonged Diarrhea in 6-to 30-Month-Old North Indian Children. Journal of Nutrition. 1108-1113.
  • Show author(s) 2011. A proposed method to investigate reliability throughout a questionnaire. BMC Medical Research Methodology. 7 pages.
  • Show author(s) 2010. Trends in incidence and mortality for triplets in Norway 1967-2006: the influence of assisted reproductive technologies. BJOG: An International Journal of Obstetrics and Gynaecology. 667-675.
  • Show author(s) 2010. Systemic Markers of Interferon-–Mediated Immune Activation and Long-Term Prognosis in Patients With Stable Coronary Artery Disease. Arteriosclerosis, Thrombosis and Vascular Biology.
  • Show author(s) 2010. Serum osteoprotegerin levels and long-term prognosis in patients with stable angina pectoris. Atherosclerosis. 644-649.
  • Show author(s) 2010. Serum B vitamin levels and risk of lung cancer. Journal of the American Medical Association (JAMA). 2377-2385.
  • Show author(s) 2010. Long- and short-term effects of tobacco smoking on circulating concentrations of B vitamins. Clinical Chemistry. 755-763.
  • Show author(s) 2010. Effect of homocysteine-lowering B vitamin treatment on angiographic progression of coronary artery disease: a western Norway B vitamin intervention trial (WENBIT) substudy. American Journal of Cardiology. 1577-1584.
  • Show author(s) 2010. Dietary intake of n-3 long-chain polyunsaturated fatty acids and coronary events in Norwegian patients with coronary artery disease. American Journal of Clinical Nutrition. 244-251.
  • Show author(s) 2010. Competing risk analysis of events 10 years after revascularization. Scandinavian Cardiovascular Journal. 279-288.
  • Show author(s) 2010. Combined analyses and extended follow-up of two randomized controlled homocysteine-lowering B-vitamin trials. Journal of Internal Medicine. 367-382.
  • Show author(s) 2009. Short-term and long-term case fatality in 11 878 patients hospitalized with a first acute myocardial infarction, 1979-2001: the Western Norway cardiovascular registry. European Journal of Cardiovascular Prevention & Rehabilitation. 621-627.
  • Show author(s) 2009. Quantitative contrast stress echocardiography in assessment of restenosis after percutaneous coronary intervention in stable coronary artery disease. European Heart Journal-Cardiovascular Imaging. 858-864.
  • Show author(s) 2009. Myocardial Contrast Echocardiography in Assessment of Stable Coronary Artery Disease at Intermediate Dobutamine-Induced Stress Level. Echocardiography. 52-60.
  • Show author(s) 2009. Cysteine, homocysteine and bone mineral density: A role for body composition? Bone. 954-958.
  • Show author(s) 2009. Cancer incidence and mortality after treatment with folic acid and vitamin B12. Journal of the American Medical Association (JAMA). 2119-2126.
  • Show author(s) 2008. Sykehusinnleggelser for hjerte- og karsykdom i Helse Vest i perioden 1992-2001. Tidsskrift for Den norske legeforening. 17-23.
  • Show author(s) 2008. Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography - A Randomized controlled trial. Journal of the American Medical Association (JAMA). 795-804.
  • Show author(s) 2008. Homocysteine, cysteine, and body composition in the Hordaland Homocysteine Study: does cysteine link amino acid and lipid metabolism? American Journal of Clinical Nutrition. 738-746.
  • Show author(s) 2008. Factor structure of the revised Jalowiec Coping Scale in patients admitted for elective coronary angiography*. Scandinavian Journal of Caring Sciences. 596-607.
  • Show author(s) 2008. Divergent associations of plasma choline and betaine with components of metabolic syndrome in middle age and elderly men and women. Journal of Nutrition. 914-920.
  • Show author(s) 2008. Comparison of the Short Form 36 and the Hospital Anxiety and Depression Scale measuring emotional distress in patients admitted for elective coronary angiography. Heart & Lung. 286-295.
  • Show author(s) 2008. Comparison of the Short Form 36 and the Hospital Anxiety and Depression Scale measuring emotional distress in patients admitted for elective coronary angiography. Heart & Lung. 286-295.
  • Show author(s) 2008. Associations between disease severity, coping and dimensions of health-related quality of life in patients admitted for elective coronary angiography - a cross sectional study. Health and Quality of Life Outcomes. 12.
  • Show author(s) 2008. Associations between disease severity, coping and dimensions of health-related quality of life in patients admitted for elective coronary angiography - a cross sectional study. Health and Quality of Life Outcomes. 12 pages.
  • Show author(s) 2007. Relations of glutamate carboxypeptidase II (GCPII) polymorphisms to folate and homocysteine concentrations and to scores of cognition, anxiety, and depression in a homogeneous Norwegian population: the Hordaland Homocysteine Study. American Journal of Clinical Nutrition. 514-521.
  • Show author(s) 2007. Plasma creatinine as a determinant of plasma total homocysteine concentrations in the Hordaland Homocysteine Study: Use of statistical modeling to determine reference limits. Clinical Biochemistry. 1209-1218.
  • Show author(s) 2007. Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease. Journal of Internal Medicine. 244-253.
  • Show author(s) 2007. Cognitive performance among the elderly and dietary fish intake: the Hordaland Health Study. American Journal of Clinical Nutrition. 1470-1478.
  • Show author(s) 2007. Changes in Atherosclerotic Plaque Volume Measured with Intracoronary Ultrasound during B-vitamin Intervention (a WENBIT substudy). Clinical Chemistry and Laboratory Medicine. A50-P44.
  • Show author(s) 2006. The hordaland homocysteine study: A community-based study of homocysteine, its determinants, and associations with disease. Journal of Nutrition. 1731-1740.
  • Show author(s) 2006. Relationship between provider-based measures of physical function and self-reported health-related quality of life in patients admitted for elective coronary angiography. Heart & Lung. 11 pages.
  • Show author(s) 2006. Relationship between probider-based measures of physical function and self-reported health-realted quality of life in pasients admitted for elective coronary angiafraphy. Heart & Lung. 90-100.
  • Show author(s) 2006. Homocysteine-lowering trials for prevention of cardiovascular events: A review of the design and power of the large randomized trials. American Heart Journal. 282-287.
  • Show author(s) 2006. Effect of vitamin B-12 treatment on haptocorrin. Clinical Chemistry. 1104-1111.
  • Show author(s) 2005. Prevalences of hyperhomocysteinemia, unfavorable cholesterol profile and hypertension in European populations. European Journal of Clinical Nutrition. 480-488.
  • Show author(s) 2005. Fc gamma receptor IIIA polymorphism as a risk-factor for coronary artery disease. Atherosclerosis. 277-282.
  • Show author(s) 2004. Changes in lifestyle and plasma total homocysteine. The Hordaland Homocysteine Study. American Journal of Clinical Nutrition. 812-819.
  • Show author(s) 2004. Changes in basal and postmethionine load concentrations of total homocysteine and cystathionine after B vitamin intervention. American Journal of Clinical Nutrition. 641-648.
  • Show author(s) 2004. Blood pressure measurements by the Keito machine. Evaluation versus office blood pressure by physicians. Blood Pressure Monitoring. 167-172.
  • Show author(s) 2004. Betaine as a determinant of postmethionine load total plasma homocysteine before and after B-vitamin supplementation. Arteriosclerosis, Thrombosis and Vascular Biology. 301-307.
  • Show author(s) 2003. Plasma Vitamin B6 Vitamers before and after Oral Vitamin B6 Treatment: A Randomized Placebo-controlled Study. Clinical Chemistry. 155-161.
  • Show author(s) 2003. Homocysteinstudien i Hordaland. Norsk Epidemiologi. 103-106.
  • Show author(s) 2002. Plasma total homocysteine and hospitalizations for cardiovascular disease: The Hordaland Homocysteine Study. Archives of Internal Medicine. 1374-1381.
  • Show author(s) 2002. Holo-Transcobalamin Is an Early Marker of Changes in Cobalamin Homeostasis. A Randomized Placebo-controlled Study. Clinical Chemistry. 1768-1771.
  • Show author(s) 2001. Plasma total homocysteine is influenced by prandial status in humans: The Hordaland Homocysteine Study. Journal of Nutrition. 1214-1216.
  • Show author(s) 2001. Plasma total homocysteine in hyper- and hypothyroid patients before and during 12 months of treatment. Clinical Chemistry. 1738-1741.
  • Show author(s) 2001. Plasma total homocysteine and cardiovascular and noncardiovascular mortality: the Hordaland Homocysteine Study. American Journal of Clinical Nutrition. 130-136.
  • Show author(s) 1999. Apolipoprotein A1 and risk for coronary artery disease. Scandinavian Cardiovascular Journal. 19.
  • Show author(s) 1998. Plasma total homocysteine levels in hyperthyroid and hypothyroid patients. Metabolism: Clinical and Experimental. 89-93.
  • Show author(s) 1998. Plasma total homocysteine levels in hyperthyroid and hypothyroid patients. Metabolism: Clinical and Experimental. 89-93.
  • Show author(s) 1998. Plasma total homocysteine levels in hyperthyroid and hypothyroid patients. Metabolism: Clinical and Experimental. 89-93.
  • Show author(s) 1998. Plasma total homocysteine levels in hyperthyroid and hypothyroid patients. Metabolism: Clinical and Experimental. 89-93.
  • Show author(s) 1998. Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study [see comments]. American Journal of Clinical Nutrition. 263-270.
  • Show author(s) 1998. Major lifestyle determinants of plasma total homocysteine distribution: The Hordaland Homocysteine Study. American Journal of Clinical Nutrition. 263-270.
  • Show author(s) 1998. Homocysteine and cardiovascular disease. Annual Review of Medicine. 31-62.
  • Show author(s) 1998. Homocysteine and cardiovascular disease. Annual Review of Medicine. 31-62.
  • Show author(s) 1998. Homocystein og koronarsykdom. Lipid-forum. 17-22.
  • Show author(s) 1997. Plasma homocysteine levels and mortality in patients with coronary artery disease. New England Journal of Medicine. 230-236.
  • Show author(s) 1997. Plasma homocysteine levels and mortality in patients with coronary artery disease. New England Journal of Medicine. 230-236.
  • Show author(s) 1997. Plasma homocysteine levels and mortality in patients with coronary artery disease. New England Journal of Medicine. 230-236.
  • Show author(s) 1997. Homocystein og livsstil. Resultater fra Homocysteinundersøkelsen i Hordaland 1992-1993. Norsk Epidemiologi. 221-224.
  • Show author(s) 1997. Homocystein og livsstil. Resultater fra Homocysteinundersøkelsen i Hordaland 1992-1993. Norsk Epidemiologi. 221-224.
  • Show author(s) 1997. Coffee consumption and plasma total homocysteine: The Hordaland Homocysteine Study. American Journal of Clinical Nutrition. 136-143.
  • Show author(s) 1997. Coffee consumption and plasma total homocysteine: The Hordaland Homocysteine Study. American Journal of Clinical Nutrition. 136-143.
  • Show author(s) 1997. Coffee consumption and plasma total homocysteine: The Hordaland Homocysteine Study. American Journal of Clinical Nutrition. 136-143.
  • Show author(s) 1996. The Hordaland homocysteine study: The opposite tails odds ratios (OTOR) reveal differential effects og gender and intake of vitamin supplements at high and low plasma homocysteine concentrations. Journal of Nutrition. 1244S-1248S.
  • Show author(s) 1996. The Hordaland homocysteine study: The opposite tails odds ratios (OTOR) reveal differential effects og gender and intake of vitamin supplements at high and low plasma homocysteine concentrations. Journal of Nutrition. 1244S-1248S.
  • Show author(s) 1996. Determinants and vitamin responsiveness of the intermediate homohypercysteinemia (> 40 _mmol/L). The Hordaland homocysteine study. Journal of Clinical Investigation. 2174-2183.
  • Show author(s) 1996. Determinants and vitamin responsiveness of the intermediate homohypercysteinemia (> 40 _mmol/L). The Hordaland homocysteine study. Journal of Clinical Investigation. 2174-2183.
  • Show author(s) 1996. Determinants and Vitamin Responsiveness of Intermediate Hyperhomocysteinemia (@z _mmol/liter). The Hordaland Homocysteine study. Journal of Clinical Investigation. 2174-2183.
  • Show author(s) 1995. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. Journal of the American Medical Association (JAMA). 1526-1533.
  • Show author(s) 1995. Kolesterolbestemmelse ved sesjon. En måte å identifisere personer med høy risiko for å utvikle hjerte- og karsykdom. Tidsskrift for Den norske legeforening. 3249-3253.
Academic lecture
  • Show author(s) 2020. Low 3-hydroxyisobutyrate (3-HIB) and high methylmalonic acid (MMA) levels in plasma reflect increased hepatic fatty acid oxidation.
  • Show author(s) 2018. Using metabolic profiling to explore molecular effects of replacing saturated fat with polyunsaturated fat- a randomized controlled dietary intervention study.
  • Show author(s) 2017. Association between dietary fat intake and coronary heart disease in middle-age adults. The Hordaland Health Study (HUSK) .
  • Show author(s) 2015. Fibrinogen And Neopterin Predict Future Myocardial Infarction Events In Patients With Stable Coronary Heart Disease. Circulation. 2015;132:A19224.
  • Show author(s) 2014. VITAMIN D STATUS AND MORTALITY IN PATIENTS WITH STABLE ANGINA.
  • Show author(s) 2013. Arvelighet av kardiovaskulær sykdom i en familiekohort med økt forekomst av preeklampsi.
  • Show author(s) 2010. Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals.
  • Show author(s) 2007. WENBIT -Western Norway B-vitamin Intervention Trial: P96, Clinical Chemistry & Laboratory Medicine. 45(5):A18, May 2007.
  • Show author(s) 2007. WENBIT - Western Norway B-vitamin intervention trial.
  • Show author(s) 2007. Total homocysteine, systemic markers of inflammation and long-term mortality in patients with stable angina.
  • Show author(s) 2007. Components of the metabolic syndrome and other cardiovascular risk factors as predictors of plasma choline and betaine.
  • Show author(s) 2007. Asymmetric and symmetric dimethylarginine are weaker predictors than homocysteine of long-term mortality in patients with stable angina.
  • Show author(s) 2002. Total homocysteine levels predicts major coronary events and mortaliy in simvastatin treated patients of 4S.
  • Show author(s) 2001. Total homocysteine predicts mortality and major coronary events also in simvastatin treated patients of 4S.
  • Show author(s) 2001. Total homocysteine predicts major coronary events and mortality in simvastatin treated patients of 4S.
  • Show author(s) 2001. Total Homocysteine Levels Predicts Major Coronary Events and Mortality in Simvastatin Treated Patients of 4S.
  • Show author(s) 2001. Homocysteine predicts mortality and coronary events in 4S patients.
  • Show author(s) 1999. Plasma levels of homocysteine are changed during treatment of hyper- and hypothyroidism.
  • Show author(s) 1999. Apolipoprotein A1 and risk for coronary artery disease.
  • Show author(s) 1998. Plasma total homocysteine: a risk factor for mortality in aortic stenosis patients.
  • Show author(s) 1997. Total mortality and serum uric acid in patients with confirmed coronary artery disease.
  • Show author(s) 1997. Plasma homocysteine predicts mortality in coronary artery diseased patients.
  • Show author(s) 1997. Plasma homocystein og livsstil. Resultater fra Homocysteinundersøkelsen i Hordaland 1992-1993. [Poster].
  • Show author(s) 1995. Plasma homocysteine and relation to coffee and tea comsimption.
  • Show author(s) 1995. Plasma homocystein og forbruk av kaffe og te.
Abstract
  • Show author(s) 2015. A genetic connection between preeclampsia and chronic hypertension in Norwegian families. Pregnancy Hypertension. 138-139.
  • Show author(s) 2013. DETERMINANTS OF VITAMIN D STATUS IN PATIENTS WITH STABLE ANGINA. Annals of Nutrition and Metabolism. 241-241.
  • Show author(s) 2013. Arvelighet av kardiovaskulær sykdom i en familiekohort med økt forekomst av preeklampsi. Gynekologen. 43-44.
  • Show author(s) 2012. Relationship between plasma choline and betaine levels and risk of acute myocardial infarction in patients with stable coronary heart disease. European Heart Journal. 132-132.
  • Show author(s) 2012. INVESTIGATING GENETIC PREDISPOSITION AND CLINICAL OCCURRENCE OF PREECLAMPSIA AND CARDIOVASCULAR DISEASE THROUGH A FAMILY-BASED DESIGN. Placenta. A82-A82.
  • Show author(s) 2009. Dietary intake of very long chain n-3 fatty acids and cardiovascular events in Norwegian patients with coronary artery disease: a cohort study. European Journal of Cardiovascular Prevention & Rehabilitation. P340-P340.
  • Show author(s) 2009. Detection of non-viable myocardium by 3T MRI in patients without obstructive coronary artery disease. Cardiology. 88-89.
  • Show author(s) 2009. Delayed contrast-enhancement and left ventricular remodelling demonstrated at high-field 3T MRI of patients with suspected coronary artery disease. Cardiology. 82-83.
  • Show author(s) 2008. The ratio of apolipoproteins ApoB/ApoA1 as a predictor of angiographic progression of atherosclerosis in patients with coronary artery disease. Circulation. E345-E346.
  • Show author(s) 2008. The effect of homocysteine-lowering B-vitamin intervention on angiographic coronary artery disease may be adverse - A WENBIT sub-study. Circulation. E334-E334.
  • Show author(s) 2008. Homocysteine lowering B-vitamin therapy improves coronary flow in patients with stable coronary artery disease, a WENBIT substudy. Circulation. E487-E487.
  • Show author(s) 2008. Homocysteine lowering B-vitamin therapy and in-stent restenosis. A WENBIT sub study. Circulation. E472-E473.
  • Show author(s) 2008. Homocysteine and markers of immune activation as predictors of mortality in stable angina patients. Circulation. E351-E351.
  • Show author(s) 2008. B6 vitamers and long term mortality in patients with stable angina. Circulation. E347-E347.
  • Show author(s) 2008. Asymmetric and symmetric dimethylarginine are weaker predictors than homocysteine of long-term mortality in both men and women with stable angina. Circulation. E342-E342.
  • Show author(s) 2007. Predictors of plasma choline and betaine: The Hordaland Homocysteine Study. Clinical Chemistry and Laboratory Medicine. A18-A19.
  • Show author(s) 2005. The Effect of Homocysteine Lowering Therapy on Inflammatory Markers Neopterin and CRP in Patients with Stable Coronary Artery Disease. A substudy of the Western Norway B-vitamin Intervention Trial (WENBIT). Haematalogica Reports. 66-66.
  • Show author(s) 2005. Effect of homocysteine lowering therapy on coronary endothelial function in patients with stable coronary artery disease. A substudy of the Western Norway B-vitamin Intervention Trial (WENBIT). European Heart Journal. 477-477.
  • Show author(s) 2005. Effect of Homocysteine Lowering Therapy on Coronary Endothelial Function in Patients with Stable Coronary Artery Disease. Haematalogica Reports. 10-10.
Academic literature review
  • Show author(s) 2015. The chromosome 9p21 CVD- and T2D-associated regions in a Norwegian population (the HUNT2 survey). International Journal of Endocrinology. 9 pages.
  • Show author(s) 2012. The Role of Long-Chained Marine N-3 Polyunsaturated Fatty Acids in Cardiovascular Disease. Cardiology Research and Practice. 15 pages.
  • Show author(s) 2010. Effects of Lowering Homocysteine Levels With B Vitamins on Cardiovascular Disease, Cancer, and Cause-Specific Mortality Meta-analysis of 8 Randomized Trials Involving 37 485 Individuals. Archives of Internal Medicine. 1622-1631.
  • Show author(s) 2010. Circulating folate, vitamin B-12, homocysteine, vitamin B-12 transport proteins, and risk of prostate cancer: a case-control study, systematic review, and meta-analysis. Cancer Epidemiology, Biomarkers and Prevention. 1632-1642.

More information in national current research information system (CRIStin)

Research groups